Skip to main content
. 2013 Nov;57(11):5315–5319. doi: 10.1128/AAC.01059-13

Fig 2.

Fig 2

In vivo antibacterial activity of PM181104 against S. aureus E710 (MRSA) in the murine septicemia model when administered i.v. at 1.25 mg/kg, 2.5 mg/kg, and 5 mg/kg compared to the vehicle control, untreated control, and standard antibiotic, i.e., linezolid given i.p. at 25 mg/kg. Survival was monitored for 10 days.